MADRID, Spain—Olezarsen (Ionis Pharmaceuticals), an antisense oligonucleotide that targets APOC3 messenger RNA (mRNA), successfully lowers triglyceride levels compared with placebo by 6 months among ...
ATLANTA, GA—Investigational agents that work by inhibiting apolipoprotein C-III (APOC3) are effective at reducing triglyceride levels, two phase IIb studies show. In Bridge-TIMI 73a, treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results